+91-120-2594300/400
Academic Experts
Academic Experts
Prof. Sudha Srivastava
Professor
sudha.srivastava@jiit.ac.in
Biography

Dr. Sudha Srivastava is an Interdisciplinary translational researcher with 20+ years of experience in R&D. Strong education professional, passionate about teaching and curriculum development for higher education.

She is a Professor at Jaypee Institute of Information Technology (JIIT), Noida, where she has been contributing since 2004. Prior to JIIT, she worked as a consultant at Indira Gandhi National Open University (IGNOU), Delhi, for the planning and development of a Post Graduate Diploma in Bioinformatics. She completed her post-doctoral training in molecular biology at the All India Institute of Medical Sciences (AIIMS) under a prestigious DBT-Post Doctoral Fellowship, structural analysis of non-structural proteins of Hepatitis E Virus.

Dr. Srivastava holds a Ph.D. in Physical Sciences from Jawaharlal Nehru University (2002), and M.Phil., M.Sc. (Hons.), and B.Sc. (Hons.) degrees in Physical Chemistry from Panjab University, Chandigarh. She has been the recipient of several fellowships, including CSIR-UGC NET-JRF, GATE, and the Jawaharlal Nehru Memorial Fund Fellowship.

Her research group specializes in the nanomaterials synthesis and biomedical applications of nanotechnology, particularly biosensor development for thyroid disorders, cancer, pathogens, and nanoparticles-based vaccine development. 

She has multiple patents to her credit, including biosensors for thyroid dysfunction and male infertility, with successful technology transfers to international industries such as Thyrolytics AB, Sweden. She also serves as Technology Advisor to Ecozyme AB, Lund, Sweden.

With several industry collaborations and funded/Consultancy projects from ICMR, DST, AICTE, Kanpur fertilizers and Chemicals Ltd (KFCL) and Ecozyme AB, Dr. Srivastava continues to advance translational nanotechnology research for healthcare and sustainable development

Research Highlights

Dr. Sudha Srivastava’s research group is engaged in advancing the biomedical applications of nanotechnology with a strong translational focus. The group’s current work centers on the development of electrochemical and lateral flow diagnostic devices for thyroid disorders, cancer, and infectious pathogens. A distinctive strength of the team lies in leveraging nanotechnology to design biosensors with enhanced stability, sensitivity, and faster response times, thereby addressing critical gaps in existing diagnostic technologies.

In addition to diagnostics, her group is actively pursuing nanoparticles-based vaccine development, exploring novel strategies for improving immunogenicity and stability. 

Their expertise spans the synthesis of diverse nanomaterials, including metallic nanoparticles (gold, silver, copper oxides), silica, graphene, core–shell structures(Au-Ag), composite nanomaterials, and polymeric nanoparticles.

Among their notable contributions is patented technology biosensors with improved sensitivity, thyroid disorder diagnosis, male infertility and enzyme nanoparticles with superior thermal and pH stability. This innovation has significant implications for extending the shelf life and performance of enzyme-based biotechnological applications.

Dr. Srivastava’s research has also found direct industrial relevance. She serves as Technology Advisor for biosensor development with Ecozyme AB, Lund, Sweden, and has successfully transferred technology for improved electrochemical electrodes to Thyrolytics AB, Sweden.

Through a combination of fundamental research and industry collaborations, her group continues to bridge the gap between nanotechnology and healthcare, working towards next-generation diagnostic tools and therapeutic solutions.

Areas Of Interest
  • Nanotechnology
  • Point-of-Care Diagnostic Device
  • Electrochemical biosensor
  • Lateral flow biosensor
  • Vaccine
Patents
  • “Thermally Stable Enzymes With Improved Biocatalytic Activity And A Process To Prepare The Same By Making Their Nanoparticles”, S. Srivastava and S. Sharma 
    Published on 16/12/2011 
    Indian Patent No 309474 (2010) (Granted Indian Patent)Date of award: March 19, 2019
  • “ Biosensor for Male Infertility” K. Punyani, S. Srivastava, M. Takwa  
    PCT Application No. PCT/EP2019/072574 (2019) 
    Published on 27-02-2020  
    (Granted European, US, Spain, Japan, , Australia, South Korea Patents) 
    Granted European Patent 3768825 (Date of award: August 11, 2021) 
    Granted Spain Patent ES2889973T3 (Date of award: January 14, 2022) 
    Granted Japan Patent JP7168265B2 (Date of award: November 9, 2022) 
    Granted United States Patent US11782052B2 (Date of award: October 10, 2023) 
    Granted Australia Patent AU2019325300B2 (Date of award: October 5, 2023) 
    Granted South Korea Patent KR102594453B1(Date of award: October 25, 2023)
  • “ Biosensor for Diagnosis of Thyroid Dysfunction” S. Srivastava, K. Punyani, M. Takwa . 
     PCT Application No. PCT/EP2019/068869 (2019) 
    Published on 16-01-2020 
    (Granted European and Spain Patents) 
    Granted European Patent 3775180 (Date of award: January 12, 2022)  
    Granted Spain Patent ES2911528T3 (Date of award: May 19, 2022)
  • “An Improved Electrode for Electrochemical Device” S. Srivastava and R. Saxena 
    Indian Patent Application No 201811012008 
    Published on 25-03-2019 
    PCT Application No. PCT/IB2019/052388 (2019)  
    Published on 03-10-2019 
    Technology Transferred to Thyrolytics AB, Sweden